1. DoRA 2.0 | Database of Research Activity
  2. Hospital and Health Services
  3. Sunshine Coast
  4. Sunshine Coast HHS Publications
Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6172
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSundar Jagannathen
dc.contributor.authorThierry Faconen
dc.contributor.authorAshraf Z. Badrosen
dc.contributor.authorMoshe Levyen
dc.contributor.authorPhilippe Moreauen
dc.contributor.authorSosana Delimpasien
dc.contributor.authorMaryana Simonovaen
dc.contributor.authorIvan Spickaen
dc.contributor.authorIryna Kriachoken
dc.contributor.authorMaria Gavriatopoulouen
dc.contributor.authorHalyna Pylypenkoen
dc.contributor.authorHolger W Auneren
dc.contributor.authorXavier Leleuen
dc.contributor.authorVadim Doroninen
dc.contributor.authorGanna Usenkoen
dc.contributor.authorRoman Hajeken
dc.contributor.authorReuben Benjaminen
dc.contributor.authorTuphan Kanti Dolaien
dc.contributor.authorDinesh Kumar Sinhaen
dc.contributor.authorChris P. Venner,en
dc.contributor.authorMamta Gargen
dc.contributor.authorMercedes Gironella Mesaen
dc.contributor.authorArtur Jurczyszynen
dc.contributor.authorTadeusz Robaken
dc.contributor.authorMonica Gallien
dc.contributor.authorWallington-Gates, Craig Thomasen
dc.contributor.authorAtanas Radinoffen
dc.contributor.authorGalina Saloguben
dc.contributor.authorDon Stevensen
dc.contributor.authorSupratik Basuen
dc.contributor.authorAnna Marina Liberatien
dc.contributor.authorHang Quachen
dc.contributor.authorVeselina S Goranova Marinovaen
dc.contributor.authorJelena Sreten Bilaen
dc.contributor.authorEirini Katodritouen
dc.contributor.authorAndrew DeCastroen
dc.contributor.authorYi Chaien
dc.contributor.authorDane R. Van Domelenen
dc.contributor.authorMoran Mishalen
dc.contributor.authorOhad S. Benturen
dc.contributor.authorJatin Shahen
dc.contributor.authorSharon Shachamen
dc.contributor.authorMichael G. Kauffmanen
dc.contributor.authorSebastian Grosickien
dc.contributor.authorPaul G. Richardsonen
dc.date.accessioned2024-08-08T03:10:18Z-
dc.date.available2024-08-08T03:10:18Z-
dc.date.issued2021-
dc.identifier.citationBlood, 2021, 138 (Supplement 1): 3793.en
dc.identifier.urihttps://dora.health.qld.gov.au/qldresearchjspui/handle/1/6172-
dc.description.abstractIntroduction: Treatment of multiple myeloma (MM) has greatly improved over the last two decades. However, most pts will relapse and develop refractory disease. Most anti-cancer regimens require dose modifications (interruption, reduction, or discontinuation) during the treatment course in order to optimize the therapeutic window; appropriate modifications improve tolerability while maintaining anti-cancer activity.en
dc.language.isoenen
dc.publisherAmerican Society of Hematologyen
dc.titleClinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Studyen
dc.typeArticleen
dc.identifier.doi10.1182/blood-2021-146003-
dc.rights.holderCraig Wallington-Gatesen
dc.identifier.journaltitleBlood-
dc.identifier.external104834744-
item.languageiso639-1en-
item.openairetypeArticle-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
Appears in Sites:Sunshine Coast HHS Publications
Show simple item record

Page view(s)

32
checked on Jan 4, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.